Long‐term impact of the low‐<scp>FODMAP</scp> diet on gastrointestinal symptoms, dietary intake, patient acceptability, and healthcare utilization in irritable bowel syndrome

O’Keeffe, Majella; Jansen, Clare; Martin, Lee; Williams, M. J.; Seamark, Leah; Staudacher, Heidi M; Irving, Peter M; Whelan, Kevin; Lomer, Miranda

doi:10.1111/nmo.13154

Cited by 149 publications

(218 citation statements)

References 52 publications

(140 reference statements)

Supporting

Mentioning

175

Contrasting

Unclassified

Order By: Relevance

“…These include gut-focused hypnotherapy, 20 a low-FODMAP diet in IBS, 41 and behavioral treatment ("biofeedback") for constipation 19 and fecal incontinence. These include gut-focused hypnotherapy, 20 a low-FODMAP diet in IBS, 41 and behavioral treatment ("biofeedback") for constipation 19 and fecal incontinence.…”

Section: Discussionmentioning

confidence: 99%

Delivery of care for functional gastrointestinal disorders: A systematic review

Basnayake

Kamm

Salzberg

et al. 2019

J of Gastro and Hepatol

View full text Add to dashboard Cite

Background A diverse range of treatments are available for the treatment of functional gastrointestinal disorders (FGIDs). Individual treatments, including drug therapies, behavioral therapy (“biofeedback”), psychological therapies, and dietary therapies, have been well validated in controlled, randomized trials and real‐life case series. However, few studies have evaluated models of delivery of care for the whole population of referred patients with an FGID. This review evaluates models of specialist outpatient care for the management of FGIDs. Methods A systematic review was performed of full‐text articles published until October 2018 in Pubmed/Medline and Embase. Studies were included if they evaluated a model of outpatient care in a specialist setting for the treatment of adult patients with an FGID and included patient‐reported outcomes comprising symptoms, quality of life, or psychological well‐being. Results Few studies have evaluated the delivery of care for the whole population of referred patients with an FGID, and there was one randomized comparison of different models of care. Two studies that evaluated the outcome of gastroenterologist‐only clinics suggested poor long‐term results. Two non‐comparative case series reported the outcome of multidisciplinary care, including gastroenterologists and psychological therapists, suggesting improved patient quality of life and psychological well‐being. Conclusions Despite the high prevalence and cost of treating FGIDs, and the availability of effective treatments, there are few data and limited randomized comparisons reporting the outcome of different types of specialist care. The few data available suggest that multidisciplinary care is superior to gastroenterologist‐only care, but this needs to be validated in prospective comparative studies.

show abstract

Section: Discussionmentioning

confidence: 99%

Delivery of care for functional gastrointestinal disorders: A systematic review

Basnayake

Kamm

Salzberg

et al. 2019

J of Gastro and Hepatol

View full text Add to dashboard Cite

show abstract

“…We believe that the evaluation of symptom response after at least 3 months of diet is indicative of the therapeutic usefulness of the diet for long-term management as required for these kinds of patients. Short-term studies have demonstrated coherent and reproducible results on overall symptoms and emerging, long-term data are also encouraging [43]. …”

Section: Discussionmentioning

confidence: 99%

“…First of all, low FODMAP diet could be considered restrictive, could lead to significant difficulties in social relationships, and may be nutritionally inadequate, particularly for what concerns fibers and B vitamins intake [41], although recent studies demonstrated the long-term efficacy and nutritional safety of the low FODMAP diet [42, 43]. Moreover, the present study showed no interference in patients’ social relationships: participants received a list of can-be-taken and to-be-avoided foods and a personalized diet based on anthropometric measurements; overall, the change in daily alimentation did not interfere with their common activities.…”

Section: Discussionmentioning

confidence: 99%

Beyond Irritable Bowel Syndrome: The Efficacy of the Low Fodmap Diet for Improving Symptoms in Inflammatory Bowel Diseases and Celiac Disease

Testa

Imperatore

Rispo

et al. 2018

Dig Dis

View full text Add to dashboard Cite

Background and Aim: To evaluate the usefulness of a low FODMAP (Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols) diet on patients with irritable bowel syndrome (IBS), non-active inflammatory bowel diseases (IBD), and celiac disease (CD) on a gluten-free diet (GFD). Methods: Dietetic interventional prospective study. IBS, IBD, and CD subjects were evaluated to check if they fulfilled the Rome III criteria. Each subject was educated to follow a low FODMAP diet after being evaluated by filling out questionnaires that assessed the quality of life (QoL) and symptoms experienced (IBS-SSS and SF-36), and was reevaluated after 1 and 3 months. Results: One hundred twenty-seven subjects were enrolled: 56 with IBS, 30 with IBD, and 41 with CD. IBS-SSS showed that abdominal symptoms improved after 1 and 3 months of diet in all subjects, with significant difference among the 3 groups at T0 (average scores IBS: 293 ± 137, IBD: 206 ± 86, CD: 222 ± 65, p < 0.001), but no difference at T3 (IBS: 88 ± 54, IBD: 73 ± 45, CD: 77 ± 49, p = ns). By analyzing the SF-36 questionnaire, we did not observe any difference between the 3 groups, in terms of response to diet (p = ns), we observed a clinical improvement from T0 to T3 for most of the questionnaire’s domains. Conclusions: A low FODMAP diet could be a valid option to counter abdominal symptoms in patients with IBS, non-active IBD, or CD on a GFD, and thus, improve their QoL and social relations.

show abstract

“…Хотя стоимость питания при этой диете оказалась зна-чительно выше (что определенным образом повли-яло на социально-экономический статус семьи), влияния на качество жизни, связанное с питанием, не было отмечено. Исследователи сделали вывод об отсутствии выраженных неблагоприятных по-бочных эффектов диеты и сочли ее приемлемой для длительного применения при СРК [42]. Мас-штабный анализ последних достижений в дието-терапии СРК, выполненный в 2017 году гастро-энтерологами клиники Королевского колледжа в Лондоне (Великобритания), подтвердил безопас-ность и эффективность диеты с низким содержа-нием FODMAP в лечении СРК у детей [43].…”

unclassified

Корекція Кишкової Мікробіоти В Лікуванні Синдрому Подразненого Кишечника В Дітей

Berezutsky

2021

View full text Add to dashboard Cite

Стаття присвячена аналізу досліджень корекції кишкової мікробіоти в дітей з синдромом подразненого кишечника. Аналізуються результати наукових досліджень, опублікованих у 2016–2018 рр. в журналах, що індексуються в наукометричних базах Scopus, Web оf Science, MedLine і PubMed. Аналіз показав, що порушення мікрофлори кишечника відіграють найважливішу роль в патогенезі синдрому подразненого кишечника в дітей. Найбільш ефективним методом корекції кишкового дисбіозу є комбіноване застосування пробіотиків і дієти з обмеженням ферментуючих вуглеводів. Найбільш ефективні схеми застосування пробіотиків поки не визначені, дане питання є предметом подальших досліджень. Позитивний ефект харчових волокон (включаючи Psyllium) на даний момент не можна вважати доведеним. Популяризація накопиченого досвіду корекції кишкової мікробіоти в дітей з синдромом подразненого кишечника є необхідною умовою підвищення ефективності лікування захворювання в умовах практичної охорони здоров’я.

show abstract

Long‐term impact of the low‐FODMAP diet on gastrointestinal symptoms, dietary intake, patient acceptability, and healthcare utilization in irritable bowel syndrome

Abstract: Low-FODMAP education is effective for long-term IBS management, enables a nutritionally adequate diet, and is broadly acceptable to patients.

Cited by 149 publications

References 52 publications

Delivery of care for functional gastrointestinal disorders: A systematic review

Delivery of care for functional gastrointestinal disorders: A systematic review

Beyond Irritable Bowel Syndrome: The Efficacy of the Low Fodmap Diet for Improving Symptoms in Inflammatory Bowel Diseases and Celiac Disease

Корекція Кишкової Мікробіоти В Лікуванні Синдрому Подразненого Кишечника В Дітей

Contact Info

Product

Resources

About